Skip to main content
Equibles
RNAZ logo

RNAZ · Transcode Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track RNAZ — free

Use RNAZ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RNAZ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.70 0.00 (-0.18%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”
View the 10-Q filed Aug 14, 2026
Market Cap
$28.78M
Shares
16.93M
Volume · Oct 20 6196 Avg daily vol (3M) 53.32K

Transcode Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Transcode Therapeutics, Inc. (RNAZ), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Key facts CIK 1829635 CUSIP 89357L501 13F (30d) 1 filings 1 filers Visit website Investor relations